FB 04 - Universitätsmedizin
Johannes Gutenberg-Universität Mainz
- 06131/17-9704 oder 9799 (Sekretariat)
- 06131/17-9669
Finn, Richard S.; Qin, Shukui; Ikeda, Masafumi et al.
IMbrave150: updated efficacy and safety by risk status in patients (pts) receiving atezolizumab (atezo) plus bevacizumab (bev) vs sorafenib (sor) as first-line treatment for unresectable hepatocellular carcinoma (HCC)SWISS MEDICAL WEEKLY. Bd. 151. 2021 S. 25-26
Finn, Richard S.; Qin, Shukui; Ikeda, Masafumi et al.
IMbrave150: Updated efficacy and safety by risk status in patients (pts) receiving atezolizumab (atezo) plus bevacizumab (bev) vs sorafenib (sor) as first-line treatment for unresectable hepatocellular carcinoma (HCC).CANCER RESEARCH. Bd. 81. H. 13. 2021
Finn, Richard S.; Qin Shukui, ?; Ikeda, Masafumi et al.
IMbrave150: Updated overall survival (OS) data from a global, randomized, open-label phase III study of atezolizumab (atezo) plus bevacizumab (bev) versus sorafenib (sor) in patients (pts) with unresectable hepatocellular carcinoma (HCC).JOURNAL OF CLINICAL ONCOLOGY. Bd. 39. H. 3. 2021
Galle, P.; Finn, R. S.; Qin, S. et al.
IMbrave150: updated overall survival (OS) data from a global, randomized, open-label Phase III study of atezolizumab (atezo) plus bevacizumab (bev) vs sorafenib (sor) in patients (pts) with unresectable hepatocellular carcinoma (HCC)ONCOLOGY RESEARCH AND TREATMENT. Bd. 44. 2021 S. 34-34
Moos, S.; Mohebiany, A. N.; Waisman, A. et al.
Imiquimod-induced psoriasis-like dermatitis in mice depends on IL-17 signaling of keratinocytesEXPERIMENTAL DERMATOLOGY. Bd. 30. H. 3. 2021 S. E20-E20
Beuker, Carolin; Strecker, Jan-Kolja; Rawal, Rajesh et al.
Immune Cell Infiltration into the Brain After Ischemic Stroke in Humans Compared to Mice and Rats: a Systematic Review and Meta-AnalysisTRANSLATIONAL STROKE RESEARCH. Bd. 12. H. 6. 2021 S. 976-990
Koch, Elias A. T.; Petzold, Anne; Wessely, Anja et al.
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Patterns of Response and Survival According to the Presence of Hepatic and Extrahepatic MetastasisCANCERS. Bd. 13. H. 13. 2021
Krebs, Franziska K.; Trzeciak, Emily R.; Zimmer, Sophia et al.
Immune signature as predictive marker for response to checkpoint inhibitor immunotherapy and overall survival in melanomaCANCER MEDICINE. Bd. 10. H. 5. 2021 S. 1562-1575
Heimes, AK; Schmidt, M
Immuno-oncology in triple-negative breast cancerJ Cancer Metastasis Treat. Bd. 7. 2021 S. 9
Boedecker, Simone C.; Luessi, Felix; Engel, Sinah et al.
Immunoadsorption and plasma exchange-Efficient treatment options for neurological autoimmune diseasesJOURNAL OF CLINICAL APHERESIS. Bd. 37. H. 1. 2021 S. 70-81